WE.SPEED.
We are pleased to announce ARENSIA´s expansion to Cluj, the second largest city in Romania.
Eleven years since the start-up of ARENSIA´s operations in Bucharest, we are excited to grow our presence in Romania and offer patients in Cluj and surroundings access to innovative therapies early on in the drug development process.
ARENSIA is collaborating with leading medical institutions in Cluj, which are serving the entire Transylvania region (population 7,5 Mio), and are equipped with the latest generation diagnostics technologies.
ARENSIA´s research facilities in Cluj will serve early phase clinical trials in oncology, haemato-oncology, as well as multi-therapeutic indications such as Rheumatology, Cardiology (incl. Interventional Cardiology), Pulmonology, Neurology, Psychiatry, Diabetes/Nutrition/Metabolic, Ophthalmology, Endocrinology, Gastroenterology, Dermatology, Nephrology, Neurology, Obstetrics-Gynaecology, and Orthopaedics-Traumatology.
ARENSIA team at this location is composed of research professionals (physicians, nurses, technicians, project coordinators, etc.) with vast experience in handling most complex exploratory protocols and innovative therapies & combinations related to first-in-man / first-in-patients study designs.
Please feel free to contact us at any stage to learn more about our newest capabilities in Cluj.
31.08.2022